Outcomes of Abdominal Wall Reconstruction Compared by Surgeon Rank
THURSDAY, May 19, 2022 (HealthDay News) -- Providing surgical fellows with operative autonomy does not appear to compromise long-term outcomes of abdominal wall reconstructions (AWRs), according to a study published online May 17 in JAMA Network Open.
Abbas M. Hassan, M.D., from University of Texas MD Anderson Cancer Center in Houston, and colleagues evaluated the long-term outcomes of AWRs performed by fellows versus AWRs performed by assistant, associate, and senior-level professors. The analysis included 810 consecutive patients who underwent AWR for ventral hernias or repair of tumor resection defects.
The researchers found that assistant professors performed the most AWRs (38.3 percent), followed by associate professors (23.5 percent), senior-level professors (21.8 percent), and microsurgical fellows (16.4 percent). Senior-level professors tended to operate on significantly older patients (mean age, 59.9 years), more patients with obesity (65.6 percent), and patients with larger defects (247.9 cm), parastomal hernias (17.2 percent), or rectus muscle violation (33.8 percent) compared with fellows and more junior surgeons. In adjusted models, there were no significant differences seen for hernia recurrence, surgical site occurrence, surgical site infection, 30-day readmission rates, or length of stay based on level of seniority. However, assistant professors and senior-level professors had lower rates of unplanned return to the operating room compared with fellows.
"Reversing the trend of diminishing operative autonomy in this domain is warranted to empower future generations of competent, independent surgeons," the authors write.
One author disclosed financial ties to the medical technology industry.
Related Posts
Playing Football, Hockey in High School Ups Odds for Stimulant Abuse
MONDAY, Aug. 15, 2022 (HealthDay News) -- Taking part in certain sports in high...
Hypertension, CHD Risk Up With History of Allergic Disorders
TUESDAY, April 12, 2022 (HealthDay News) -- Adults with a history of allergic...
Research Supporting Homeopathy Is Often Biased, of Poor Quality: Review
WEDNESDAY, March 16, 2022 (HealthDay News) -- Homeopathy's effectiveness may be...
U.S. Buys 600,000 Doses of New COVID Treatment Still Awaiting FDA Approval
FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. government has bought 600,000...